Soleil Securities Initiates Coverage on Auxilium Pharmaceuticals (AUXL) with a Buy; Potential Xiaflex FDA Approval Could Lead Shares Higher
Tweet Send to a Friend
Soleil Securities initiates coverage on Auxilium Pharmaceuticals (Nasdaq: AUXL) with a Buy. Price target $31.
Soleil analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Soleil analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
